Cargando…

Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis

A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the right lung and diagnosed as lung squamous cell carcinoma. Anti-cancer treatments were not performed because of the presence of advanced interstitia...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Mari, Horio, Yukihiro, Takihara, Takahisa, Enokida, Keito, Miyaoka, Masashi, Hirabayashi, Kenichi, Ohshinden, Kana, Hattori, Shigeaki, Takahashi, Fuminari, Takahashi, Genki, Tanaka, Jun, Takiguchi, Hiroto, Niimi, Kyoko, Ito, Yoko, Hayama, Naoki, Oguma, Tsuyoshi, Asano, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946518/
https://www.ncbi.nlm.nih.gov/pubmed/33028767
http://dx.doi.org/10.2169/internalmedicine.5125-20
_version_ 1783663068450914304
author Takahashi, Mari
Horio, Yukihiro
Takihara, Takahisa
Enokida, Keito
Miyaoka, Masashi
Hirabayashi, Kenichi
Ohshinden, Kana
Hattori, Shigeaki
Takahashi, Fuminari
Takahashi, Genki
Tanaka, Jun
Takiguchi, Hiroto
Niimi, Kyoko
Ito, Yoko
Hayama, Naoki
Oguma, Tsuyoshi
Asano, Koichiro
author_facet Takahashi, Mari
Horio, Yukihiro
Takihara, Takahisa
Enokida, Keito
Miyaoka, Masashi
Hirabayashi, Kenichi
Ohshinden, Kana
Hattori, Shigeaki
Takahashi, Fuminari
Takahashi, Genki
Tanaka, Jun
Takiguchi, Hiroto
Niimi, Kyoko
Ito, Yoko
Hayama, Naoki
Oguma, Tsuyoshi
Asano, Koichiro
author_sort Takahashi, Mari
collection PubMed
description A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the right lung and diagnosed as lung squamous cell carcinoma. Anti-cancer treatments were not performed because of the presence of advanced interstitial pneumonia and chronic respiratory failure. Cyclosporine A was tapered to avoid suppression of anti-tumor immunity, and pirfenidone was initiated. Within 2 months, the tumor had shrunk to 10 mm in diameter and remained regressed for 9 months. This is the first report of a non-hematologic solid organ tumor responding to the discontinuation of immunosuppressants.
format Online
Article
Text
id pubmed-7946518
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-79465182021-03-15 Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis Takahashi, Mari Horio, Yukihiro Takihara, Takahisa Enokida, Keito Miyaoka, Masashi Hirabayashi, Kenichi Ohshinden, Kana Hattori, Shigeaki Takahashi, Fuminari Takahashi, Genki Tanaka, Jun Takiguchi, Hiroto Niimi, Kyoko Ito, Yoko Hayama, Naoki Oguma, Tsuyoshi Asano, Koichiro Intern Med Case Report A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the right lung and diagnosed as lung squamous cell carcinoma. Anti-cancer treatments were not performed because of the presence of advanced interstitial pneumonia and chronic respiratory failure. Cyclosporine A was tapered to avoid suppression of anti-tumor immunity, and pirfenidone was initiated. Within 2 months, the tumor had shrunk to 10 mm in diameter and remained regressed for 9 months. This is the first report of a non-hematologic solid organ tumor responding to the discontinuation of immunosuppressants. The Japanese Society of Internal Medicine 2020-10-07 2021-02-15 /pmc/articles/PMC7946518/ /pubmed/33028767 http://dx.doi.org/10.2169/internalmedicine.5125-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Takahashi, Mari
Horio, Yukihiro
Takihara, Takahisa
Enokida, Keito
Miyaoka, Masashi
Hirabayashi, Kenichi
Ohshinden, Kana
Hattori, Shigeaki
Takahashi, Fuminari
Takahashi, Genki
Tanaka, Jun
Takiguchi, Hiroto
Niimi, Kyoko
Ito, Yoko
Hayama, Naoki
Oguma, Tsuyoshi
Asano, Koichiro
Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
title Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
title_full Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
title_fullStr Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
title_full_unstemmed Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
title_short Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
title_sort regression of lung squamous cell carcinoma after the withdrawal of cyclosporin a combined with pirfenidone treatment in a patient with idiopathic pulmonary fibrosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946518/
https://www.ncbi.nlm.nih.gov/pubmed/33028767
http://dx.doi.org/10.2169/internalmedicine.5125-20
work_keys_str_mv AT takahashimari regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT horioyukihiro regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT takiharatakahisa regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT enokidakeito regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT miyaokamasashi regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT hirabayashikenichi regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT ohshindenkana regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT hattorishigeaki regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT takahashifuminari regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT takahashigenki regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT tanakajun regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT takiguchihiroto regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT niimikyoko regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT itoyoko regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT hayamanaoki regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT ogumatsuyoshi regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis
AT asanokoichiro regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis